⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4485501 | 0.79 | — | — | |
| SCHEMBL414574 | 0.76 | — | — | |
| SCHEMBL3857199 | 0.76 | — | — | |
| SCHEMBL5160421 | 0.76 | — | — | |
| SCHEMBL5160419 | 0.76 | — | — | |
| SCHEMBL7789921 | 0.70 | — | — | |
| SCHEMBL5303 | 0.65 | — | — | |
| SCHEMBL385398 | 0.65 | — | — | |
| SCHEMBL5868713 | 0.65 | — | — | |
| SCHEMBL3375280 | 0.63 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1335 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024141004-A1 | COMPOUNDS AS INHIBITORS OF MACROPHAGE MIGRATION INHIBITORY FACTOR AND THE USE THEREOF | NANJING IMMUNOPHAGE BIOTECH CO., LTD (CN) | 2024-07-04 | — | — | WO | claimed |
| WO-2024118887-A1 | N-PHENYL-PYRAZOLO[1,5-A]PYRIDINE-3-CARBOXAMIDE DERIVATIVES AS WILD TYPE C-KIT KINASE INHIBITORS FOR THE TREATMENT OF URTICARIA | BLUEPRINT MEDICINES CORPORATION (US) | 2024-06-06 | — | — | WO | claimed |
| CN-118076602-A | Heteroaryl-acetylenes, pharmaceutical compositions thereof and their therapeutic uses | 嘉兴优博生物技术有限公司 | 2024-05-24 | — | — | CN | claimed |
| US-20240101546-A1 | HETEROARYL-ACETYLENES, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC APPLICATIONS | EUBULUS BIOTHERAPEUTICS INC (CN) | 2024-03-28 | — | — | US | claimed |
| WO-2024051766-A1 | MOLECULAR GLUE COMPOUND BASED ON CEREBLON PROTEIN DESIGN AND USE THEREOF | 标新生物医药科技(上海)有限公司 | 2024-03-14 | — | — | WO | claimed |
| WO-2024046327-A1 | P38α-MK2 INHIBITOR COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND USE THEREOF | 长春金赛药业有限责任公司 | 2024-03-07 | — | — | WO | claimed |
| EP-3740206-B1 | INHIBITORS OF CYCLIN-DEPENDENT KINASE 7 (CDK7) | SYROS PHARMACEUTICALS INC (US) | 2024-03-06 | — | — | EP | claimed |
| CN-117229268-A | Hydrazide-containing nuclear transport modulators and uses thereof | 卡尔约药物治疗公司 | 2023-12-15 | — | — | CN | claimed |
| EP-4073057-B1 | NEW FYN AND VEGFR2 KINASE INHIBITORS | Rottapharm Biotech Srl (IT) | 2023-11-29 | — | — | EP | claimed |
| WO-2023207875-A1 | CDK INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND THERAPEUTIC APPLICATIONS | ONQUALITY PHARMACEUTICALS CHINA LTD. (CN) | 2023-11-02 | — | — | WO | claimed |
| WO-1990001476-A1 | A PROCESS FOR THE ENANTIOSPECIFIC SYNTHESIS OF INTERMEDIATES FOR HEXAHYDRO-BENZO[d]NAPHTHO[2,1-b]AZEPINES | SCHERING CORPORATION (US) | 1990-02-22 | — | — | WO | claimed |
| EP-0354686-A1 | A process for the enantiospecific synthesis of intermediates for hexahydro-benzo[d] naphto[2,1-b] azepines | SCHERING CORPORATION (US) | 1990-02-14 | — | — | EP | claimed |
| WO-1990000853-A2 | METHOD OF TREATING NEUROLOGICAL DISORDERS | SCHERING CORPORATION (US) | 1990-02-08 | — | — | WO | claimed |
| EP-0351733-A1 | Use of 2,3,4,5-tetrahydro-1H-3-benzazepines in the treatment of neurological disorders | SCHERING CORPORATION (US) | 1990-01-24 | — | — | EP | claimed |
| WO-1989000561-A1 | FUSED BENZAZEPINES | SCHERING CORPORATION (US) | 1989-01-26 | — | — | WO | claimed |
| EP-0299101-A1 | Fused benzazepines | SCHERING CORPORATION (US) | 1989-01-18 | — | — | EP | claimed |
| EP-0254737-A1 | FUSED BENZAZEPINES. | SCHERING CORP (US) | 1988-02-03 | — | — | EP | claimed |
| WO-1987004430-A2 | FUSED BENZAZEPINES | SCHERING CORPORATION (US) | 1987-07-30 | — | — | WO | claimed |
| EP-0230270-A2 | Fused benzazepines | SCHERING CORPORATION (US) | 1987-07-29 | — | — | EP | claimed |
| EP-0005299-A1 | Substituted 1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines, process for the preparation thereof, and pharmaceutical compositions containing them | Technobiotic Ltd. (CH) | 1979-11-14 | — | — | EP | claimed |